GlobalData on MSN

Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment

Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.
MassDevice

Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment

Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...
The Manila Times

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

Siemens Healthineers, AiM team up; Procept completes study enrollment

Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...

Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock

Chicago Capital added 969,592 shares of PROCEPT BioRobotics, an estimated $27.32 million trade based on the average share price in the first quarter of 2026. Quarter-end position value rose by $16.57 ...

Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best robotic surgery stocks to buy. PROCEPT BioRobotics ...